Antagonism between bacteriostatic and bactericidal antibiotics is prevalent

Paolo S. Ocampo, Viktória Lázár, Balázs Papp, Markus Arnoldini, Pia Abel Zur Wiesch, Róbert Busa-Fekete, Gergely Fekete, Csaba Pál, Martin Ackermann, Sebastian Bonhoeffer

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

Combination therapy is rarely used to counter the evolution of resistance in bacterial infections. Expansion of the use of combination therapy requires knowledge of how drugs interact at inhibitory concentrations. More than 50 years ago, it was noted that, if bactericidal drugs are most potent with actively dividing cells, then the inhibition of growth induced by a bacteriostatic drug should result in an overall reduction of efficacy when the drug is used in combination with a bactericidal drug. Our goal here was to investigate this hypothesis systematically. We first constructed time-kill curves using five different antibiotics at clinically relevant concentrations, and we observed antagonism between bactericidal and bacteriostatic drugs. We extended our investigation by performing a screen of pairwise combinations of 21 different antibiotics at subinhibitory concentrations, and we found that strong antagonistic interactions were enriched significantly among combinations of bacteriostatic and bactericidal drugs. Finally, since our hypothesis relies on phenotypic effects produced by different drug classes, we recreated these experiments in a microfluidic device and performed time-lapse microscopy to directly observe and quantify the growth and division of individual cells with controlled antibiotic concentrations. While our single-cell observations supported the antagonism between bacteriostatic and bactericidal drugs, they revealed an unexpected variety of cellular responses to antagonistic drug combinations, suggesting that multiple mechanisms underlie the interactions.

Original languageEnglish
Pages (from-to)4573-4582
Number of pages10
JournalAntimicrobial agents and chemotherapy
Volume58
Issue number8
DOIs
Publication statusPublished - Aug 2014

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Antagonism between bacteriostatic and bactericidal antibiotics is prevalent'. Together they form a unique fingerprint.

  • Cite this

    Ocampo, P. S., Lázár, V., Papp, B., Arnoldini, M., Zur Wiesch, P. A., Busa-Fekete, R., Fekete, G., Pál, C., Ackermann, M., & Bonhoeffer, S. (2014). Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrobial agents and chemotherapy, 58(8), 4573-4582. https://doi.org/10.1128/AAC.02463-14